Sponsored content by
Software for biobanks, clinical trials, cohorts and biorepositories, although share many common characteristics, are often very specific and personalised. It is important to be able to rely on a software application that can provide the functionality and solution to each project’s key requirements.
Modular and Evolutive
MBioLIMS BioBanking is a modular solution allowing our clients to personalise the system to match their specific projects and trials. The diversity provided by the numerous modules’ functionalities in the system facilitates different requirements and projects goals.
This also supports expansion and evolution as the biobank grows, or new projects are created as new modules can be added to suit any requirements.
The references section of this article includes some examples of projects and details on how they are managing samples and clinical information. Although they are quite different, they are both using MBioLIMS BioBanking software but a different combination of modules.
MBioLIMS BioBanking is used to centralise sample data, donor information, consents and clinical data in a variety of ways. This may be as central biobank, or a multi-site / department system with restricted data rules and processes. Using roles and profiles in the system, client administrators can provide software access to all required users, and specify the data they can see, functionality they have access to tailor the required access and experience for different staff and levels.
As client’s data requirements can vary, MBioLIMS can collect patient data, and anonymise patient’s nominative data asrequired. Client administrators can use in-built functionality to configure new eCRF questionnaires and create custom fields to capture any data, in the required format. All data captured including custom fields can be searched and reported on.
Compartmentalisation
Whatever the requirement for software access, MBioLIMS compartmentalisation options can provide distinct, segregated access for as many sites as needed, in addition to a centralised control for the main centre of operations.
This could be a simple scenario of a single study, with the data and parameters designed to match the information collected.
Some clients require a more versatile system with multiple sites, and a growing number of studies.
Collecting sites are configured to access MBioLIMS and can capture sample data and clinical information upon collection. This creates a timepoint of data each time samples are collected providing integral information that groups and annotates samples taken at the same time. For these reasons, the system can be used for longitudinal studies and clinical trials by many collecting sites.
Samples can be shipped from collecting sites to a central biobank for storage and further processing, with every step and process audited through the sample’s lifecycle.
Conclusion
The overall choice of software is an important one to ensure a professional and streamlined data management process. Modular choices, self-administration, intuitive and easy to use interfaces are just some of the elements that makes MBioLIMS the right solution for our clients.
With the current pandemic ongoing, we are supporting biobanks and biorepositories that are creating new studies and projects to study Covid-19. Apply for 20% Discount
For more information please visit our website https://www.modul-bio.com/
References
- March 24th 2020, The ICAReB Platform: A Human Biobank for the Institut Pasteur and Beyond at https://openbioresources.metajnl.com/articles/10.5334/ojb.66/
- April 3rd 2020, CRYOSTEM Biobank: A National Prospective, Standardized Collection to Better Characterize Allogeneic Hematopoietic Stem Cell Transplantation Complications at https://openbioresources.metajnl.com/articles/10.5334/ojb.58/
